查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573718

心血管数位解决方案市场、机会、成长动力、产业趋势分析与预测，2024-2032

Cardiovascular Digital Solutions Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球心血管数位解决方案市场估值为955 亿美元，预计2024 年至2032 年复合年增长率为6.1%。市场扩张。

远距医疗的技术进步在推动市场成长方面发挥关键作用。这些创新不仅支持心血管疾病的监测和诊断，还满足了对远距医疗解决方案不断增长的需求。穿戴式技术，包括智慧手錶和带有心电图感测器的健身追踪器，正在改变心血管护理的模式。此类设备有助于持续监测心律、血压和其他生命体征，从而向患者和医疗保健专业人员提供即时资料。这种及时检测异常并远端监控健康趋势的能力是市场成长的主要催化剂。

整个行业是应用程式、元件、部署模式、最终用途和区域。

市场按应用细分为心臟监测和诊断、CVD 健康资讯学、心臟復健计划和其他领域。心臟监测和诊断领域占据市场主导地位，到2023 年，其价值将达到569 亿美元。疾病等流行疾病凸显了这一点。

从部署角度来看，市场分为基于云端的解决方案和本地解决方案。 2023 年，基于云端的解决方案占据了 53.2% 的主导市场。这些云端解决方案提供了可扩展的基础设施，使医疗保健提供者能够无缝调整资源以回应需求波动。这种适应性对于管理不同的患者资料量和根据需要增强功能至关重要。

2023年，北美心血管数位解决方案市场估值为355亿美元，预测分析期间复合年增长率为5.4%。该地区冠状动脉疾病和高血压等心血管疾病的高发生率刺激了对确保持续监测和复杂诊断的数位解决方案的需求。此外，北美强大的医疗基础设施及其对数位健康技术的广泛采用简化了心血管数位解决方案的整合和应用。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 心臟病盛行率不断上升
      • 远距医疗的技术进步
      • 新产品的认知度和可近性不断提高
      • 越来越多地采用资料驱动的医疗保健模式
    • 产业陷阱与挑战
      • 资料安全问题
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势
  • 差距分析
  • 政策格局

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按应用划分，2021 - 2032 年

  • 主要趋势
  • 心臟监测与诊断
  • 心血管疾病健康资讯学
  • 心臟復健计划
  • 其他应用

第 6 章：市场估计与预测：按组成部分，2021 - 2032 年

  • 主要趋势
  • 装置
  • 软体

第 7 章：市场估计与预测：按部署模式，2021 - 2032 年

  • 主要趋势
  • 基于云端
  • 本地部署

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院和诊所
  • 居家护理
  • 其他最终用户

第 9 章：市场估计与预测：按地区划分，2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章：公司简介

  • AliveCor, Inc.
  • Apple Inc.
  • Baxter
  • Cardiac Insight, Inc.
  • Cardiotrack
  • eviCore healthcare
  • Garmin
  • GE Healthcare
  • HeartFlow
  • iRhythm Technologies, Inc.
  • Myia Health
  • Omron Healthcare
  • Qardio
  • Verily Life Sciences LLC,
  • Welch Allyn
简介目录
Product Code: 11047

The Global Cardiovascular Digital Solutions Market was valued at USD 95.5 billion in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2032. The market expansion is fueled by the rising prevalence of cardiac conditions, technological strides in telehealth, and heightened awareness and accessibility of emerging products.

Telehealth's technological advancements play a pivotal role in propelling the market growth. These innovations not only bolster the monitoring and diagnosis of cardiovascular conditions but also cater to the surging demand for remote healthcare solutions. Wearable technologies, including smartwatches and fitness trackers with ECG (electrocardiogram) sensors, are transforming the landscape of cardiovascular care. Such devices facilitate the continuous monitoring of heart rhythms, blood pressure, and other vital signs for delivering real-time data to patients and healthcare professionals. This capability to detect anomalies promptly and monitor health trends remotely is a primary catalyst for the market growth.

The overall industry is application, component, deployment mode, end-use, and region.

The market is segmented by application into cardiac monitoring and diagnosis, CVD health informatics, cardiac rehab programs, and other areas. Dominating the market, the cardiac monitoring and diagnosis segment was valued at USD 56.9 billion in 2023. Given that cardiovascular diseases (CVDs) rank among the top global causes of morbidity and mortality, the prevalent conditions like hypertension, arrhythmias, and coronary artery disease underscore the demand for precise diagnostic tools and continuous monitoring.

Deployment-wise, the market is divided into cloud-based and on-premise solutions. In 2023, cloud-based solutions commanded a dominant market share of 53.2%. These cloud solutions provide a scalable infrastructure, enabling healthcare providers to adjust resources seamlessly in response to demand fluctuations. Such adaptability is vital for managing diverse patient data volumes and enhancing capabilities as required.

In 2023, North America cardiovascular digital solutions market was valued at USD 35.5 billion, with projections indicating a CAGR of 5.4% during the analysis period. The region's high prevalence of cardiovascular diseases, such as coronary artery disease and hypertension, fuels the demand for digital solutions that ensure continuous monitoring and sophisticated diagnostics. Furthermore, North America's robust healthcare infrastructure and its widespread embrace of digital health technologies streamline the integration and application of cardiovascular digital solutions.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of cardiac conditions
      • 3.2.1.2 Technological advancements in telehealth
      • 3.2.1.3 Rising awareness and accessibility of the new products
      • 3.2.1.4 Growing adoption of data driven healthcare model
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Data security concerns
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Future market trends
  • 3.9 GAP analysis
  • 3.10 Policy landscape

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Cardiac monitoring and diagnosis
  • 5.3 CVD health informatics
  • 5.4 Cardiac rehab programs
  • 5.5 Other applications

Chapter 6 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Devices
  • 6.3 Software

Chapter 7 Market Estimates and Forecast, By Deployment Mode, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Cloud-based
  • 7.3 On-premise

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Homecare
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AliveCor, Inc.
  • 10.2 Apple Inc.
  • 10.3 Baxter
  • 10.4 Cardiac Insight, Inc.
  • 10.5 Cardiotrack
  • 10.6 eviCore healthcare
  • 10.7 Garmin
  • 10.8 GE Healthcare
  • 10.9 HeartFlow
  • 10.10 iRhythm Technologies, Inc.
  • 10.11 Myia Health
  • 10.12 Omron Healthcare
  • 10.13 Qardio
  • 10.14 Verily Life Sciences LLC,
  • 10.15 Welch Allyn